Home LiteratureArticle Details
PMID: 9399950 Published · ppublish English Case Reports Journal Article Research Support, Non-U.S. Gov't

An interleukin-2 receptor gamma chain mutation with normal thymus morphology.

The Journal of clinical investigation ·Vol. 100 ·No. 12 ·1997-12-15 ·Pages 3036-43

Sharfe N, Shahar M, Roifman CM

Abstract

One of the most common human immunodeficiencies is an X-linked condition arising from mutations of the gamma subunit of the interleukin-2 receptor (IL-2Rgamma). The IL-2Rgamma protein is one chain of the heterotrimeric (alpha, beta, gamma) IL-2 receptor, but also participates in the formation of the IL-4, 7, 9, and 15 receptor complexes. The diagnosis of X-linked SCID is usually relatively simple due to the distinctive immunological presentation; IL-2Rgamma-deficient patients typically lacking mature T lymphocytes (T-B+). However, it is becoming clear that this merely represents one extreme of a potential range of clinical presentations. We describe here a novel mutation of the human IL-2Rgamma chain (R222C) resulting in an unusual immunological phenotype. Although clinically immunodeficient, this patient has normal numbers of peripheral T and B cells, responds normally to mitogenic stimuli, and unusually, has a normal thymus gland. This IL-2Rgamma mutation is distinctive in that the protein is sufficiently stable to be expressed at the cell surface. While the T cell receptor repertoire appears complete, suggesting normal T cell differentiation occurs, patient T cells demonstrate a reduced ability to bind IL-2 and this appears sufficient to cause a deficiency in their ability to participate in antigenic responses. Early clinical recognition of this phenotype is critical as a delay in diagnosis may result in a fatal infection.

MeSH Terms
Animals COS Cells Humans Infant Janus Kinase 3 Ligands Male Mutation Protein-Tyrosine Kinases/metabolism Receptors, Interleukin-2/genetics,metabolism Severe Combined Immunodeficiency/genetics,immunology,metabolism,pathology Thymus Gland/immunology,pathology
Chemicals
Ligands Receptors, Interleukin-2 Protein-Tyrosine Kinases JAK3 protein, human Janus Kinase 3
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Sharfe N
Division of Immunology and Allergy, Department of Pediatrics, Hospital for Sick Children and the University of Toronto, Toronto, Canada M5G 1X8.
Shahar M
Roifman C M
References (31)
31 references, click to expand
  1. Exogenous IL-7 promotes the growth of CD3-CD4-CD8-CD44+CD25+/- precursor cells and blocks the differentiation pathway of TCR-alpha beta cells in fetal thymus organ culture.
    J Immunol. 1993 Apr 1;150(7):2706-16 PMID: 8095954
  2. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.
    Science. 1992 Jan 17;255(5042):306-12 PMID: 1549776
  3. The IL-2/IL-2 receptor system: a current overview.
    Cell. 1993 Apr 9;73(1):5-8 PMID: 8462103
  4. The IL-2 receptor complex: its structure, function, and target genes.
    Annu Rev Immunol. 1993;11:245-68 PMID: 8476561
  5. Characterization of the human interleukin-2 receptor gamma chain gene.
    J Biol Chem. 1993 Jun 25;268(18):13601-8 PMID: 8514792
  6. Interleukin-7: a cofactor for V(D)J rearrangement of the T cell receptor beta gene.
    Science. 1993 Jul 2;261(5117):93-5 PMID: 7686307
  7. Refinement of linkage of human severe combined immunodeficiency (SCIDX1) to polymorphic markers in Xq13.
    Am J Hum Genet. 1993 Jul;53(1):176-84 PMID: 8317482
  8. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4.
    Science. 1993 Dec 17;262(5141):1874-7 PMID: 8266076
  9. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor.
    Science. 1993 Dec 17;262(5141):1877-80 PMID: 8266077
  10. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor.
    Science. 1993 Dec 17;262(5141):1880-3 PMID: 8266078
  11. Expansion of CD3+CD4-CD8- T cell population expressing high levels of IL-5 in Omenn's syndrome.
    Clin Exp Immunol. 1994 Jan;95(1):14-21 PMID: 8287598
  12. Interleukin-2 (IL-2) receptor gamma chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding.
    Eur J Immunol. 1994 Feb;24(2):475-9 PMID: 8299698
  13. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.
    Science. 1994 Mar 11;263(5152):1453-4 PMID: 8128231
  14. Heterodimerization of the IL-2 receptor beta- and gamma-chain cytoplasmic domains is required for signalling.
    Nature. 1994 May 26;369(6478):330-3 PMID: 8183373
  15. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2.
    Nature. 1994 Jul 14;370(6485):151-3 PMID: 8022485
  16. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.
    Nature. 1994 Jul 14;370(6485):153-7 PMID: 8022486
  17. The molecular basis of X-linked severe combined immunodeficiency: the role of the interleukin-2 receptor gamma chain as a common gamma chain, gamma c.
    Immunol Rev. 1994 Apr;138:61-86 PMID: 8070818
  18. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
    J Exp Med. 1994 Nov 1;180(5):1955-60 PMID: 7964471
  19. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
    Science. 1994 Nov 11;266(5187):1042-5 PMID: 7973658
  20. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.
    Science. 1994 Nov 11;266(5187):1045-7 PMID: 7973659
  21. The X-ray structure of a growth hormone-prolactin receptor complex.
    Nature. 1994 Dec 1;372(6505):478-81 PMID: 7984244
  22. The interleukin-2 and interleukin-4 receptors studied by molecular modelling.
    Structure. 1994 Sep 15;2(9):839-51 PMID: 7529123
  23. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
    J Clin Invest. 1995 Mar;95(3):1169-73 PMID: 7883965
  24. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.
    J Exp Med. 1995 Apr 1;181(4):1519-26 PMID: 7699333
  25. The primary immunodeficiencies.
    N Engl J Med. 1995 Aug 17;333(7):431-40 PMID: 7616993
  26. JAK3 protein tyrosine kinase mediates interleukin-7-induced activation of phosphatidylinositol-3' kinase.
    Blood. 1995 Sep 15;86(6):2077-85 PMID: 7662955
  27. Close linkage of the locus for X chromosome-linked severe combined immunodeficiency to polymorphic DNA markers in Xq11-q13.
    Proc Natl Acad Sci U S A. 1987 Nov;84(21):7576-9 PMID: 3478714
  28. Effect of IL-7 on the growth of fetal thymocytes in culture.
    J Immunol. 1989 Aug 15;143(4):1215-22 PMID: 2787360
  29. Structural design and molecular evolution of a cytokine receptor superfamily.
    Proc Natl Acad Sci U S A. 1990 Sep;87(18):6934-8 PMID: 2169613
  30. IL-7 maintains the T cell precursor potential of CD3-CD4-CD8- thymocytes.
    J Immunol. 1991 May 1;146(9):3068-73 PMID: 1826704
  31. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans.
    Cell. 1993 Apr 9;73(1):147-57 PMID: 8462096
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1997-12-15
Pages
3036-43
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC508516
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]